ITEMS IN AFP WITH KEYWORD:
Coronary Artery Disease
Using coronary CTA to screen for CAD in adults with type 1 or type 2 diabetes and no indication of existing CAD does not improve outcomes more than standard care.
Ticagrelor is an alternative to clopidogrel for secondary prevention of cardiovascular death in patients with acute coronary syndrome. In an international study it was found to be more effective, but patients in the United States did not experience superior outcomes.
Optimal management of myocardial infarction in the subacute period focuses on improving the discharge planning process, implementing therapies early to prevent recurrent myocardial infarction, and avoiding hospital readmission. Evidence-based guidelines for the care of patients with acute coronary s...
Beta-blocker therapy was not associated with a reduced risk of adverse cardiovascular events in adults with a prior MI, known CAD without prior MI, or three or more known risk factors for CAD.
Sep 1, 2012 Issue
Should Family Physicians Use Coronary Artery Calcium Scores to Screen for Coronary Artery Disease? Yes: Screening Improves CAD Risk Management in Selected Patients [Editorials: Controversies in Family Medicine]
Yes: Screening Improves CAD Risk Management in Selected Patients. Sudden death is often the first manifestation of atherosclerotic coronary artery disease (CAD). One-third of deaths from CAD in the Atherosclerosis Risk in Communities study occurred without warning signs, and there was no prior diagnosis of CAD in most of these persons.
Sep 1, 2012 Issue
Should Family Physicians Use Coronary Artery Calcium Scores to Screen for Coronary Artery Disease? No: Screening is Unproven, Expensive, and Potentially Harmful [Editorials: Controversies in Family Medicine]
No: Screening is Unproven, Expensive, and Potentially Harmful. Coronary artery calcium (CAC) scores have been recommended as a way to screen for coronary artery disease (CAD). Before we get too enthusiastic about this expensive new test, remember that a good screening test must perform significantly...
All patients with stable coronary artery disease require medical therapy to prevent disease progression and recurrent cardiovascular events. Three classes of medication are essential to therapy: lipid-lowering, antihypertensive, and antiplatelet agents. Lipid-lowering therapy is necessary to decreas...
Feb 15, 2011 Issue
Using Nontraditional Risk Factors in Coronary Heart Disease Risk Assessment: Recommendation Statement [U.S. Preventive Services Task Force]
The U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient to assess the balance of benefits and harms of using the nontraditional risk factors discussed in this statement to screen asymptomatic men and women with no history of coronary heart disease (CHD) to prevent CHD events.
Feb 15, 2011 Issue
Using Nontraditional Risk Factors in Coronary Heart Disease Risk Assessment [Putting Prevention into Practice]
Case study: A 47-year-old man with no history of coronary heart disease (CHD), diabetes mellitus, or any CHD risk equivalent asks about smoking cessation therapies. His past laboratory results include a total cholesterol level of 230 mg per dL (5.96 mmol per L) and a high-density lipoprotein level of 35 mg per dL (0.91 mmol per L).
Sudden cardiac death is a major public health problem, affecting 500,000 patients in the United States annually. An implantable cardioverter-defibrillator (ICD) can terminate malignant ventricular arrhythmias and has been shown to improve survival in high-risk populations. Although sudden cardiac de...